Disclosure Of First-Time Adoption [Text Block]

Biocartis Group NV - Filing #3122957

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	30,284,000 EUR	—	—	5,843,000 EUR	631,722,000 EUR	7,502,000 EUR	443,363,000 EUR	220,302,000 EUR	30,284,000 EUR	—	—	526,405,000 EUR	—	33,897,000 EUR	—	5,572,000 EUR	33,897,000 EUR	711,874,000 EUR	6,862,000 EUR	220,657,000 EUR	—	—	455,343,000 EUR	36,824,000 EUR	220,657,000 EUR	5,153,000 EUR	711,874,000 EUR	6,102,000 EUR	36,824,000 EUR
Comprehensive income	—	65,274,000 EUR	65,003,000 EUR	—	—	—	—	—	—	271,000 EUR	65,274,000 EUR	—	71,481,000 EUR	—	419,000 EUR	—	—	—	—	—	71,481,000 EUR	71,062,000 EUR	—	—	—	—	—	—	—
Profit (loss)	—	65,381,000 EUR	65,381,000 EUR	—	—	—	—	—	—	—	65,381,000 EUR	—	71,472,000 EUR	—	—	—	—	—	—	—	71,472,000 EUR	71,472,000 EUR	—	—	—	—	—	—	—